Evidence map›Paper›PMID 24960161›Full record

ArticleThe Journal of clinical investigation2014

RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing.

Henrike Maatz, Marvin Jens, Martin Liss, Sebastian Schafer, Matthias Heinig, Marieluise Kirchner, Eleonora Adami, Carola Rintisch, Vita Dauksaite, Michael H Radke and 7 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 148 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
148citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

148 citing papers in PubMed, 1 synthesis or guideline pooled it, 222 citations in OpenAlex.

  1. Geographical and Ethnic Heterogeneity in Genetic Dilated Cardiomyopathies.International journal of molecular sciences · 2026
    Pooled it
  2. Contribution of Noncanonical Splice Variants toCirculation. Genomic and precision medicine · 2021
    Trial
  3. Article
  4. Review
  5. Article
  6. RBM20 variants disrupt CaSignal transduction and targeted therapy · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

88 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Henrike Maatz
Marvin Jens
Martin Liss
Sebastian Schafer
Matthias Heinig
Marieluise Kirchner
Eleonora Adami
Carola Rintisch
Vita Dauksaite
Michael H Radke
Matthias Selbach
Paul J R Barton
Stuart A Cook
Nikolaus Rajewsky
Michael Gotthardt
Markus Landthaler
Norbert Hubner
Max Delbrück Center · DEDuke-NUS Medical School · SGGerman Centre for Cardiovascular Research · DEMax Planck Institute for Molecular Genetics · DENational Heart Centre Singapore · SG

Funding

British Heart Foundation SP/10/10/28431Medical Research Council MC_U120085815
6 · The paper itself

Abstract

Mutations in the gene encoding the RNA-binding protein RBM20 have been implicated in dilated cardiomyopathy (DCM), a major cause of chronic heart failure, presumably through altering cardiac RNA splicing. Here, we combined transcriptome-wide crosslinking immunoprecipitation (CLIP-seq), RNA-seq, and quantitative proteomics in cell culture and rat and human hearts to examine how RBM20 regulates alternative splicing in the heart. Our analyses revealed the presence of a distinct RBM20 RNA-recognition element that is predominantly found within intronic binding sites and linked to repression of exon splicing with RBM20 binding near 3' and 5' splice sites. Proteomic analysis determined that RBM20 interacts with both U1 and U2 small nuclear ribonucleic particles (snRNPs) and suggested that RBM20-dependent splicing repression occurs through spliceosome stalling at complex A. Direct RBM20 targets included several genes previously shown to be involved in DCM as well as genes not typically associated with this disease. In failing human hearts, reduced expression of RBM20 affected alternative splicing of several direct targets, indicating that differences in RBM20 expression may affect cardiac function. Together, these findings identify RBM20-regulated targets and provide insight into the pathogenesis of human heart failure.

Indexed as

Alternative SplicingAnimalsBase SequenceBinding SitesCardiomyopathy, DilatedCohort StudiesExonsHeart FailureHumansMutationMyocardiumMyocytes, CardiacRatsRats, Sprague-DawleyRibonucleoprotein, U1 Small NuclearRibonucleoprotein, U2 Small NuclearRBM20 protein, ratribonucleic acid binding motif protein 20, humanRibonucleoprotein, U1 Small NuclearRibonucleoprotein, U2 Small NuclearRNA-Binding ProteinsRNA PrecursorsRNA Splice Sites

Identifiers

PMID24960161
PMCPMC4109538
OpenAlexW2118496707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.